An anti-Ebola prototype drug has helped a critically ill doctor from Sierra Leone, according to the latest study. The medic, who was flown to a German hospital in September with severe Ebola symptoms and discharged a month later, fully recovered.
The study, published in medical journal The Lancet, has urged clinical evaluation of the treatment.
The 38-year-old doctor was airlifted and transferred to Frankfurt University Hospital in September, showing vascular leakage and failure of several organs.
“In view of the urgency for action in light of the current epidemic, where validated therapies are desperately needed, the efficacy of FX06 should soon be assessed in clinical trials or at least by standardized collection of data from patients with Ebola virus disease who received it in a compassionate use setting,” the patient’s medics wrote in The Lancet.